ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Atropos Health Leverages Google Cloud to Generate Actionable Clinical Evidence for Healthcare Institutions from Healthcare Data, Rapidly and Securely

Atropos Health, a pioneer in translating real-world clinical data into personalized real-world evidence and insights, today announced that it has optimized Atropos Health’s GENEVA™ OS (Generative Evidence Acceleration Operating System) to now work with Google Cloud's healthcare offerings, including Google Cloud’s Healthcare Data Engine (HDE), leveraging HDE application programming interfaces and BigQuery. This powerful pairing enables customers to efficiently and securely convert data into valuable insights and evidence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240130637982/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

With Google Cloud and Atropos Health, health systems can spend less time maintaining infrastructure and more time leveraging insights from their data for improved operational efficiency and clinical decision making. When Google Cloud customers deploy GENEVA OS and ChatRWD™, the first generative AI application incorporating direct chat-to-database capability, they can gain valuable insights on day one. Upon the federated installation of GENEVA OS in their internal cloud data environment, customers can ask clinical questions immediately via the Green Button Informatics Consult, and receive observational publication-grade research study evidence within 48 hours. In addition, GENEVA OS customers can access Alexandria™, a collection of tens of thousands of existing studies, including active clinical trial designs that provide immediate answers to clinical questions asked by their peers and other healthcare and life sciences organizations. The existing studies are available on day one in Alexandria and can be rerun on local data, generating novel content and evidence for customer use. The combined technology enhances the efficiency of deployments while meeting the enterprise-grade security expectations of major health systems.

"Atropos Health is committed to enabling rapid real-world evidence with the highest levels of data privacy and security in healthcare. Atropos Health's services facilitate secure access to real-world evidence, in compliance with regulations like HIPAA," said Dr. Brigham Hyde, CEO and co-founder of Atropos Health. "Google Cloud's real-time capabilities align with our delivery model to the clinicians and researchers who rely on the Atropos Evidence Network as a trusted resource requiring insights at the pace of care."

“In the coming year, the medical community will continue to navigate various uses of generative AI to reduce inefficiencies in clinical processes,” said Aashima Gupta, global director, Healthcare Strategy and Solutions, Google Cloud. “We look forward to working with Atropos Health to drive impactful innovation and improve healthcare for everyone.”

About Atropos Health

Atropos Health is the developer of Geneva OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X @AtroposHealth.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.